Document is current
Any future updates will be listed below
-
Authors
Kirupaharan, Nila
Edalat, Camellia https://orcid.org/0009-0008-9016-7272
Dalvin, Lauren A. https://orcid.org/0000-0001-9710-4284
Mishra, Kapil
Marshall, Rayna https://orcid.org/0000-0002-6961-1278
Xu, Hannah
Francis, Jasmine H.
Berkenstock, Meghan
- License Information
-
More Information
Article History
Received: 25 October 2024
Revised: 22 July 2025
Accepted: 20 August 2025
First Online: 29 August 2025
Competing interests
: Nila Kirupaharan: none, Camellia Edalat: none, Lauren A. Dalvin: Supported by CTSA Grant Number KL2 TR002379 from the National Center for Advancing Translational Science (NCATS), Consultant for Ideaya Biosciences, Kapil Mishra: none, Rayna Marshall: none, Hannah Xu: none, Jasmine H. Francis: none, Meghan Berkenstock: consultant for Eyepoint pharmaceuticals, Seagen Incorporated, Sanofi, Abbvie, and Glaxo Smith Kline Pharmaceuticals.
